Madopar Depot

Levodopa/Benserazide, the active ingredient in Madopar Depot, is a Levodopa/dopa decarboxylase inhibitor combination presented as an extended‑release oral tablet for oral use. The depot formulation provides sustained plasma concentrations, helping to reduce the frequency of dosing and improve symptom control. It is employed to manage the motor symptoms of Parkinson's disease in adult patients.

GNH USA supplies Madopar Depot as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution.

Madopar Depot is used in the treatment of Parkinsonian disorders, targeting the dopaminergic pathway to improve motor function.

- Parkinson's disease (early stage): improves tremor, rigidity and bradykinesia, facilitating daily activities. - Parkinson's disease (advanced stage with motor fluctuations): reduces off‑time and stabilizes symptom control. - Parkinsonism secondary to drug‑induced dopamine blockade: may be considered under specialist supervision to restore dopaminergic tone.

Adverse reactions to Madopar Depot are reported across a range of frequencies.

Common Side Effects: - Nausea - Vomiting - Dizziness or light‑headedness - Orthostatic hypotension - Headache - Insomnia

Serious or Rare Side Effects: - Dyskinesia (involuntary movements) - Psychiatric disturbances (hallucinations, confusion) - Severe orthostatic hypotension leading to falls - Cardiac arrhythmias - Neuroleptic malignant‑like syndrome - Anaphylactic or severe allergic reactions

When prescribing Madopar Depot, clinicians should observe several safety measures.

- Dose titration: start low and increase gradually to minimize side effects. - Monitor for dyskinesia: adjust dose if involuntary movements appear. - Assess renal and hepatic function: use caution in impairment. - Avoid abrupt discontinuation: may precipitate neuroleptic malignant‑like syndrome. - Pregnancy and lactation: use only if benefit outweighs risk (category unknown). - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Madopar Depot can interact with several drug classes; careful review is required.

Major Interactions (Avoid): - Non‑selective MAO‑B inhibitors (e.g., phenelzine): risk of hypertensive crisis. - Anticholinergic agents at high doses: may mask levodopa side effects. - COMT inhibitors without dose adjustment: increased levodopa levels. - Strong D2 antagonists (e.g., haloperidol): may reduce therapeutic effect. - High‑dose pyridoxine (vitamin B6): accelerates peripheral levodopa metabolism.

Moderate Interactions (Monitor Closely): - SSRIs and SNRIs: possible serotonin syndrome. - Beta‑blockers: may enhance orthostatic hypotension. - Diuretics: increase risk of low blood pressure. - Iron or calcium supplements: reduce levodopa absorption if taken simultaneously. - Alcohol: may exacerbate dizziness and sedation.